| docetaxel / Generic mfg. |
NCT00127933: XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer |
|
|
| Completed | 4 | 157 | US | capecitabine [Xeloda], Taxotere, Herceptin (HER2-neu positive patients only) | Hoffmann-La Roche | Breast Cancer | 04/09 | 07/09 | | |
NCT00774241: PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer |
|
|
| Withdrawn | 4 | 0 | RoW | bevacizumab [Avastin], docetaxel | Hoffmann-La Roche | Breast Cancer | 11/13 | 11/13 | | |
NCT01301729: A Study of Herceptin (Trastuzumab) in Combination With a Taxane in Participants With HER2-Positive Breast Cancer Who Relapsed After (Neo)Adjuvant Herceptin Treatment |
|
|
| Completed | 4 | 32 | RoW | Docetaxel, Paclitaxel, Trastuzumab, Herceptin | Hoffmann-La Roche | Breast Cancer | 07/14 | 07/14 | | |
NCT01660542: An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer |
|
|
| Completed | 4 | 96 | RoW | Neoadjuvant Chemotherapy with Docetaxel | Yonsei University | Locally Advanced Breast Cancer | 06/15 | 06/15 | | |
| Completed | 4 | 49 | Europe | Bevacizumab, Avastin, Paclitaxel, Docetaxel | Hoffmann-La Roche | Breast Cancer | 12/15 | 12/15 | | |
| Completed | 4 | 226 | US | TAC chemotherapy, TC chemotherapy, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy, TCH chemotherapy, T + trastuzumab followed by CEF + trastuzumab, Dose dense AC followed by T + trastuzumab, Dose dense AC followed by T + trastuzumab + pertuzumab, PTH followed by dose dense AC of FEC | Agendia, University of South Florida, University of Miami, Morton Plant Mease Health Care, AdventHealth, Plano Cancer Center, Ohio State University Comprehensive Cancer Center, University of Oklahoma, University of South Alabama | Breast Cancer | 02/16 | 06/17 | | |
| Completed | 4 | 142 | Canada | G-CSF, granulocyte-colony stimulating factor, Ciprofloxacin, Cipro, Cipro XR, Proquin XR | Ottawa Hospital Research Institute | Breast Cancer | 09/17 | 09/17 | | |
